TARAProtara Therapeutics, Inc.Healthcare · Biotechnologyas of 2026-09-16
Horizon

Issued 2026-09-16 at $3.62 · now $3.62 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, TARA has typically landed between $2.69 and $5.08 — a range of −25.8% to +40.4% from the issuance price $3.62.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

2,968 overlapping 1 month windows · 2014-10-222026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($3.62) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where TARA has typically landed a month from the 2026-09-16 close of $3.62 — the range is history, not a prediction.

$2.69worst · -25.8%$5.08best · +40.4%
  • now $3.62 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $3.49 (-3.7%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $3.08$3.89
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $2.69$5.08
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 2,968 windows spanning 2014-10-22 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2019-03-26−88.8%−88.8%+0.0%
2019-03-27−88.1%−88.1%+0.0%
2019-03-25−87.7%−87.7%+9.7%
3 best
2019-12-20+226.8%+0.0%+226.8%
2019-12-24+200.2%+0.0%+216.6%
2019-12-19+193.2%−3.4%+193.2%

2,968 overlapping windows · 2014-10-222026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~12 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
67%
+11.2%
n=12
Feb
33%
−1.0%
n=12
Mar
42%
−5.9%
n=12
Apr
42%
−9.2%
n=12
May
25%
+3.8%
n=12
Jun
42%
−3.5%
n=12
Jul
42%
−4.1%
n=12
Aug
42%
−3.0%
n=12
Sep
25%
−2.5%
n=12
Oct
45%
+1.3%
n=11
Nov
83%
+14.4%
n=12
Dec
50%
+4.0%
n=12

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$8$32026-06-29: 1 insider sale, $882K — Shefferman Jesse2026-04-08: 1 insider sale, $6K — Zummo Jacqueline2026-04-01: 1 insider sale, $119K — Zummo Jacqueline2026-04: 2 open-market sales, $125K2026-06: 1 open-market sale, $882K↑ buys↓ salesdirector Shefferman Jesse — Sale on 2026-06-29, filed 2 days after the tradeofficer Zummo Jacqueline — Sale on 2026-04-08, filed 1 day after the tradeofficer Zummo Jacqueline — Sale on 2026-04-01, filed 1 day after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-06-29Shefferman JessedirectorSale215,687 @ $4.09$882K−23.0% of holding−6.9%not yet — horizon still open721,832Form 4 · filed 2 days after the trade
2026-04-08Zummo JacquelineofficerSale1,134 @ $5.40$6K−1.2% of holding−5.3%not yet — horizon still open94,827Form 4 · filed 1 day after the trade
2026-04-01Zummo JacquelineofficerSale22,598 @ $5.26$119K−19.1% of holding−4.4%not yet — horizon still open95,961Form 4 · filed 1 day after the trade
2025-05-14Levy Richard SdirectorPurchase20,000 @ $3.19$64K+64.5% of holding−1.3%+52.4%51,000Form 4 · filed 2 days after the trade
2025-03-26Zummo JacquelineofficerSale21,224 @ $4.53$96K−17.7% of holding−1.5%−21.7%98,861Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

67 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-06-30Shefferman JessedirectorGift7,000700,832Form 4
2026-06-30Shefferman JessedirectorGift4,000696,832Form 4
2026-06-30Shefferman JessedirectorGift14,000707,832Form 4
2026-06-30Shefferman JessedirectorGift5,000691,832Form 4
2026-06-29Shefferman JessedirectorOption exercise215,687937,519Form 4
2026-06-29Shefferman JessedirectorOption exercise215,687141,313Form 4
2026-06-15Solomon Michael EdwarddirectorAward / grant31,00031,000Form 4
2026-06-15Levy Richard SdirectorAward / grant31,00031,000Form 4
2026-06-15BESHAR LUKE MdirectorAward / grant31,00031,000Form 4
2026-06-15Flannelly Barry PdirectorAward / grant31,00031,000Form 4
2026-06-15GARCEAU ROGERdirectorAward / grant31,00031,000Form 4
2026-06-15Huang JanedirectorAward / grant31,00031,000Form 4
2026-06-15SARGEN GREGORYdirectorAward / grant31,00031,000Form 4
2026-06-15Smith CynthiadirectorAward / grant31,00031,000Form 4
2026-06-02CONKLING WILLIAMdirectorWithheld for tax6,00869,992Form 4
2026-01-26Shefferman JessedirectorWithheld for tax8,7321,021,832Form 4
2026-01-26Zummo JacquelineofficerWithheld for tax3,724118,559Form 4
2026-01-26Fabbio PatrickdirectorWithheld for tax3,26164,115Form 4
2026-01-26Fry HannahofficerWithheld for tax1,45742,723Form 4
2026-01-20Shefferman JessedirectorWithheld for tax16,3221,030,564Form 4
2026-01-20Zummo JacquelineofficerWithheld for tax6,578122,283Form 4
2026-01-20Fabbio PatrickdirectorWithheld for tax3,06367,376Form 4
2026-01-20Fry HannahofficerWithheld for tax2,13244,180Form 4
2026-01-16Shefferman JessedirectorAward / grant87,0001,046,886Form 4
2026-01-16Nicacio Leonardo VianaofficerAward / grant158,000158,000Form 4
2026-01-16Zummo JacquelineofficerAward / grant30,000128,861Form 4
2026-01-16Zummo JacquelineofficerAward / grant180,000180,000Form 4
2026-01-16Fabbio PatrickdirectorAward / grant175,000175,000Form 4
2026-01-16Fabbio PatrickdirectorAward / grant28,00070,439Form 4
2026-01-16CONKLING WILLIAMdirectorAward / grant158,000158,000Form 4
2026-01-16CONKLING WILLIAMdirectorAward / grant26,00076,000Form 4
2026-01-16Fry HannahofficerAward / grant55,00055,000Form 4
2026-01-16Shefferman JessedirectorAward / grant524,000524,000Form 4
2026-01-16Nicacio Leonardo VianaofficerAward / grant26,00078,181Form 4
2026-01-16Fry HannahofficerAward / grant9,50046,312Form 4
2025-06-27Shefferman JessedirectorGift3,367959,886Form 4
2025-06-27Shefferman JessedirectorGift10,200963,253Form 4
2025-06-26Shefferman JessedirectorGift3,400973,453Form 4
2025-06-26Shefferman JessedirectorGift1,700976,853Form 4
2025-06-24Shefferman JessedirectorGift300,000659,886Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.